ridaforolimus

Showing 1 posts of 1 posts found.

Merck plans cancer drug submissions later this year

June 7, 2011
Research and Development, Sales and Marketing Merck & Co, ridaforolimus

Merck & Co is to submit its oral investigational cancer drug ridaforolimus to European and US regulators later this year …

The Gateway to Local Adoption Series

Latest content